-2.75 (-0.17%) Sun Pharmaceutical Industries has informed about a Press Release dated July 27, 2016 titled ‘Almirall and Sun Pharma enter into a License Agreement for Tildrakizumab in Europe for Psoriasis.’
The above information is a part of company’s filings submitted to BSE.